In addition, an intensive contact between physicians and T1DM patients undergoing CSII therapy is essential to achieve a greater level of knowledge to appropriately carry out insulin dose adjustment for dietary intake, specifically carbohydrate counting, lifestyle factors, and in particular, disease management. This evidence concerns the gene INS and type 1 diabetes mellitus.